Purchase Order HHSN272201400026P
Award Date
10/30/13
Potential Completion Date
10/30/13
Potential Value
$3K
Federal Agency
NIAID DEA OA Acquisitions
Ultimate Awardee
Illumina, Inc.
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for a sample preparation kit. The contract has a ceiling value of $3,889.60 and a completion date of August 12, 2015. Illumina is a manufacturer of genetic sequencing instruments and reagents, and has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $3,161.60 and is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic applications. The contract does not have a set-aside designation. Based on Illumina's history...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract provides for the supply of reagents, kits, and supplies to support Illumina's 2000 and 4000 sequencing systems. The contract has a ceiling value of $99,939.56 and an ultimate completion date of March 3, 2021. Illumina has previously held other prime federal contracts and sub-grants...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the purchase of laboratory equipment and supplies. The award has a ceiling value of $457,844.10 and a completion date of April 30, 2010. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, has previously received prime contract and subcontract awards from federal...
This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina Next Generation Sequencing (NGS) Kits. The contract has a ceiling value of $14,284.57 and a completion date of September 11, 2015. Illumina is a manufacturer of sequencing and array-based genomic analysis solutions, and has previously received other prime federal...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract is valued at $13,613.60 and was awarded on September 8, 2014, with a completion date of October 5, 2014. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genetic sequencing and analysis equipment, has provided a range of sequencing systems, reagents, and...
This firm fixed-price purchase order contract was awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) on September 16, 2015 for $19,603.58. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contracts and sub-awards from agencies such as...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for laboratory equipment and supplies. The contract has a ceiling value of $7,673.09 and a final completion date of August 31, 2015. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract provides for Illumina to supply a range of...